Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Breath-based Naltrexone Adherence Tool
NCT02194764Completed
- Sponsor
- Xhale Assurance
- Start
- Jun 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of naltrexone transdermal patch in opioid use disorder (OUD), sponsored by Xhale Assurance. Primary endpoints: Concentration of 2-butanol determined by gas chromatography mass spectroscopy (GC-MS) at 6 months and breath concentration versus time. Started Jun 2014; status: completed.
02
Drugs
naltrexone transdermal patch
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02194764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194764.